Mechanism of cholesterol efflux in humans after infusion of reconstituted high-density lipoprotein

European Heart Journal

Volumn 33, Issue 5, 2012, Pages 657-665

  Hoang, Anh ^a   Drew, Brian G ^a   Low, Hann ^a   Remaley, Alan T ^b   Nestel, Paul ^a   Kingwell, Bronwyn A ^a   Sviridov, Dmitri ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Cholesterol; Lipids; Lipoproteins

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; RECONSTITUTED HIGH DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR BI; UNCLASSIFIED DRUG;

ARTICLE; CHOLESTEROL TRANSPORT; HUMAN; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANALYSIS OF VARIANCE; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; BIOLOGICAL TRANSPORT; CELLS, CULTURED; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; HUMANS; INFUSIONS, INTRAVENOUS; LIPOPROTEINS, HDL; MALE; PLASMA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRITIUM;

EID: 84857967567     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr103     Document Type: Article

References (17)

1. Shaw JA, Bobik A, Murphy A, Kanellakis P, Blombery P, Mukhamedova N, Woollard K, Lyon S, Sviridov D, Dart AM. Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque. Circ Res 2008; 103:1084-1091.
2. Nicholls SJ, Tuzcu EM, Sipahi I, Schoenhagen P, Crowe T, Kapadia S, Nissen SE. Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I Milano. J Am Coll Cardiol 2006;47:992-997.
3. Sviridov D, Hoang A, Ooi E, Watts G, Barrett PHR, Nestel P. Indices of reverse cholesterol transport in subjects with metabolic syndrome after treatment with rosuvastatin. Atherosclerosis 2008;197:732-739. (Pubitemid 351417870)
4. de la Llera-Moya M, Drazul-Schrader D, Asztalos BF, Cuchel M, Rader DJ, Rothblat GH. The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages. Arterioscler Thromb Vasc Biol 2010;30: 796-801.
5. Nanjee MN, Cooke CJ, Olszewski WL, Miller NE. Concentrations of electrophoretic and size subclasses of apolipoprotein A-I-containing particles in human peripheral lymph. Arterioscler Thromb Vasc Biol 2000;20: 2148-2155.
6. Asztalos BF, de la Llera-Moya M, Dallal GE, Horvath KV, Schaefer EJ, Rothblat GH. Differential effects of HDL subpopulations on cellular ABCA1-and SR-BI-mediated cholesterol efflux. J Lipid Res 2005;46:2246-2253. (Pubitemid 41377476)
7. Sviridov D, Mukhamedova N, Remaley AT, Chin-Dusting J, Nestel P. Antiatherogenic functionality of high density lipoprotein: how much vs. how good. J Atheroscler Thromb 2008;15:52-62.
8. Sviridov D, Nestel P. Dynamics of reverse cholesterol transport; protection against atherosclerosis. Atherosclerosis 2002;161:245-254. (Pubitemid 34219176)
9. Patel S, Drew BG, Nakhla S, Duffy SJ, Murphy AJ, Barter PJ, Rye K-A, Chin-Dusting J., Hoang A, Sviridov D, Celermajer DS, Kingwell BA. Reconstituted high-density lipoprotein increases plasma high-density lipoprotein antiinflammatory properties and cholesterol efflux capacity in patients with Type 2 diabetes. J Am Coll Cardiol 2009;53:962-971.
10. Mukhamedova N, Escher G, D'Souza W, Tchoua U, Grant A, Krozowski Z, Bukrinsky M, Sviridov D. Enhancing apolipoprotein A-I-dependent cholesterol efflux elevates cholesterol export from macrophages in vivo. J Lipid Res 2008;49: 2312-2322.
11. Sviridov D, Chin-Dusting J, Nestel P, Kingwell B, Hoang A, Olchawa B, Starr J, Dart A. Elevated HDL cholesterol is functionally ineffective in cardiac transplant recipients: evidence for impaired reverse cholesterol transport. Transplantation 2006;81:361-366. (Pubitemid 43255720)
12. Huang Y, von Eckardstein A, Assmann G. Cell-derived unesterified cholesterol cycles between different HDLs and LDL for its effective esterification in plasma. Arterioscler Thromb 1993;13:445-458. (Pubitemid 23075635)
13. Castro GR, Fielding CJ. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. Biochemistry 1988;27:25-29. (Pubitemid 18036281)
14. Sviridov D, Fidge N. Pathway of cholesterol efflux from human hepatoma cells. Biochim Biophys Acta 1995;1256:210-230.
15. Cuchel M, Lund-Katz S, de la Llera-Moya M, Millar JS, Chang D, Fuki I, Rothblat GH, Phillips MC, Rader DJ. Pathways by which reconstituted highdensity lipoprotein mobilizes free cholesterol from whole body and from macrophages. Arterioscler Thromb Vasc Biol 2010;30:526-532.
16. Dobiasova M, Frohlich JJ. Advances in understanding of the role of lecithin cholesterol acyltransferase (LCAT) in cholesterol transport. Clin Chim Acta 1999;286: 257-271. (Pubitemid 29406113)
17. Atger VM, de la Llera Moya M, Stoudt GW, Rodrigueza WV, Phillips MC, Rothblat GH. Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells. J Clin Invest 1997;99:773-780. (Pubitemid 27097681)